Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2

Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2

• Description: Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.
• CAS Number: 9007-83-4
• UniProt: Q969Z3
• Host: Rabbit
• Immunogen: A portion of amino acids 270-300 from the human protein was used as the immunogen for the Mitochondrial amidoxime reducing component 2 antibody.
• Clonality: Polyclonal
• Isotype: Ig
• Applications: WB, FACS, IHC-P
• Format: Purified
• Buffer: In 1X PBS, pH 7.4, with 0.09% sodium azide
• Reconstitution: Aliquot the Mitochondrial amidoxime reducing component 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
• Limitations: This Mitochondrial amidoxime reducing component 2 antibody is available for research use only.